How many insider trades does FilingIQ track for NPCE?

FilingIQ tracks 248 Form 4 insider transactions for NPCE (NeuroPace Inc), covering filings from Apr 21, 2021 onwards. 10 of those were filed in the last 90 days.

Are NPCE insiders net buyers or net sellers?

Across the full Form 4 history for NPCE, 8 transactions (3%) were open-market purchases and 69 (28%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NPCE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is NPCE in?

NeuroPace Inc (NPCE) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $487.29M.

NPCE insider trading

NasdaqGM Healthcare

NeuroPace Inc — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

248

Last 90 days

Buys / sells

3% / 28%

Market cap

$487.29M

About NeuroPace Inc

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet and patient data management system; and nSight Platform, which facilitates ongoing patient monitoring and streamlines patient support. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Company website: www.neuropace.com

NPCE insider activity at a glance

FilingIQ has scored 248 insider transactions for NPCE since Apr 21, 2021. The most recent filing in our index is dated Mar 24, 2026.

Across the full history, 8 open-market purchases and 69 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NPCE insider trades is 49.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NPCE trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for NPCE?: FilingIQ tracks 248 Form 4 insider transactions for NPCE (NeuroPace Inc), covering filings from Apr 21, 2021 onwards. 10 of those were filed in the last 90 days.
Are NPCE insiders net buyers or net sellers?: Across the full Form 4 history for NPCE, 8 transactions (3%) were open-market purchases and 69 (28%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NPCE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is NPCE in?: NeuroPace Inc (NPCE) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $487.29M.

Methodology & sources

Every NPCE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.